Veterinary Monoclonal Antibodies Market Overview:

Jadhavar Business Intelligence is a Business Consultancy Firm that has published a detailed analysis of the “ Veterinary Monoclonal Antibodies Market ”. The report includes key business insights, demand analysis, pricing analysis, and competitive landscape. The analysis in the report provides an in-depth aspect at the current status of the Veterinary Monoclonal Antibodies Market.

Request a Free Sample Copy or View Report Summary:https://www.jadhavarbusinessintelligence.com/request-sample-report/veterinary-monoclonal-antibodies-market/1180 

Veterinary Monoclonal Antibodies Market Scope and Methodology:

The Veterinary Monoclonal Antibodies Market requires a mix of both qualitative and quantitative research methods. Veterinary Monoclonal Antibodies Market information is gathered through different research methods including expert advice, primary and secondary research, both qualitative and quantitative. Primary research gathers important data from interviews, surveys, questionnaires, and input from industry experts, customers and other sources either in person or over the phone.

The report provides in-depth analysis on different strategies used by leading companies, such as partnerships, mergers, acquisitions, and collaborations. The report conducted a SWOT analysis to evaluate the company's market position through identifying its strengths, weaknesses, opportunities, and threats. Analytical techniques, such as examining investment returns, conducting a feasibility study, and using Porter's five forces analysis, were employed to assess the Veterinary Monoclonal Antibodies Market. The bottom-up approach was used to determine the global and regional Veterinary Monoclonal Antibodies Market sizes.

Veterinary Monoclonal Antibodies Market Regional Insights:

The Veterinary Monoclonal Antibodies Market report is segmented into various key countries. Countries such as North America (United States, Canada, Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN countries, other APAC countries), South America (Brazil), and the Middle East and Africa.

Request a Free Sample Copy or View Report Summary:https://www.jadhavarbusinessintelligence.com/request-sample-report/veterinary-monoclonal-antibodies-market/1180 

Veterinary Monoclonal Antibodies Market Segmentation:

By Animal Type,
Based on the classification of animals, the market is divided into dogs (canine), cats (feline), livestock, and other companion animals. In 2025, the segment for dogs led the Veterinary Monoclonal Antibodies Market, representing 48.11% of the overall market share. Treatments involving monoclonal antibodies for dogs accounted for the highest number of patients receiving such therapies, surpassing all other patients (including those in human medicine), and were frequently utilized to address allergy-related dermatitis and osteoarthritis pain in canines. Data collected from 2022 to 2024 indicated that around 12 to 15% of pet dogs in these regions were afflicted with chronic allergic dermatitis necessitating medical intervention. Monoclonal antibody therapies offered extended periods of relief from itching compared to previous treatments, with some patients enjoying up to 2022 to 2024 weeks of comfort from a single injection. Furthermore, the adoption of canine medical treatments was on the rise, aided by the expansion of pet insurance coverage within many established veterinary healthcare systems in the western world. Consequently, pet pharmaceutical companies were advancing canine-specific biologic (monoclonal antibody) initiatives within their development pipelines, thereby further solidifying this product segment and maintaining its dominance in the veterinary monoclonal antibody market.

By Product Type,
Based on the classification of products, the market is divided into Anti-IL-31 Monoclonal Antibodies, Anti-NGF Monoclonal Antibodies, Immune-Modulating mAbs, and Other Targeted mAbs. In 2025, the Anti-IL-31 Monoclonal Antibodies segment led the Veterinary Monoclonal Antibodies Market, representing 41.32% of the overall market share. In recent years, numerous veterinarians have been opting for anti-interleukin 31 (IL-31) monoclonal antibodies when addressing allergies or skin irritation issues in companion animals. These treatments have become an increasingly favored option for the long-term management of chronic skin conditions in dogs. Clinical studies conducted between 2021 and 2024 indicated that anti-IL-31 medications were alleviating itching symptoms by approximately 70% after just one treatment cycle. Many pet owners have shown a preference for biologic injection-based medications over prolonged corticosteroid use due to a reduced risk of side effects associated with this treatment. Furthermore, several veterinary pharmaceutical companies have been concentrating their research and development initiatives on the creation of therapeutic pipelines, particularly focusing on medications targeting IL-31, which has led to an increase in the availability of biologically based treatments in veterinary practices. All these elements have contributed to reinforcing the sustained dominance of anti-IL-31 medications within the Veterinary Monoclonal Antibodies Market.

Veterinary Monoclonal Antibodies Market Key Players:

Zoetis Inc.

Elanco Animal Health Incorporated

Merck & Co., Inc.

Boehringer Ingelheim Animal Health

Ceva Santé Animale

Vetoquinol S.A.

Dechra Pharmaceuticals PLC

Phibro Animal Health Corporation

Biogenesis Bago S.A.

Vetigenics Inc.

Animab AB

VETmAb BIO

WuXi Biologics

Bio‑Rad Laboratories, Inc.

SouthernBiotech

Get to Know More About This Market Study:https://www.jadhavarbusinessintelligence.com/market-research-report/veterinary-monoclonal-antibodies-market/1180 

Key questions answered in the Veterinary Monoclonal Antibodies Market are:

What is Veterinary Monoclonal Antibodies Market?

What is the growth rate of the Veterinary Monoclonal Antibodies Market?

Which are the factors expected to drive the Veterinary Monoclonal Antibodies Market growth?

What are the upcoming opportunities and trends for the Veterinary Monoclonal Antibodies Market?

Who are the leading companies and what are their portfolios in Veterinary Monoclonal Antibodies Market?

What are the recent industry trends that can be implemented to generate additional revenue streams for the Veterinary Monoclonal Antibodies Market?

Who are the key players in the Veterinary Monoclonal Antibodies Market?

What are the different segments of the Veterinary Monoclonal Antibodies Market?

Which is the fastest growing region in the Veterinary Monoclonal Antibodies Market?

What growth strategies are the players considering to increase their presence in Veterinary Monoclonal Antibodies Market?

What is the CAGR at which the Veterinary Monoclonal Antibodies Market will grow during the forecast period?

What segments are covered in the Veterinary Monoclonal Antibodies Market?

Latest cutting-edge research from Jadhavar Business Intelligence is now trending:

Seed Treatment Market https://www.jadhavarbusinessintelligence.com/market-research-report/seed-treatment-market/1163 
Micro Irrigation Systems Market https://www.jadhavarbusinessintelligence.com/market-research-report/micro-irrigation-systems-market/1164 

Key Offerings:

Past Market Size and Competitive Landscape

Past Pricing and price curve by region

Market Size, Share, Size & Forecast by different segment

Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region

Market Segmentation – A detailed analysis by segment with their sub-segments and Region

Competitive Landscape – Profiles of selected key players by region from a strategic perspective

Competitive landscape – Market Leaders, Market Followers, Regional player

Competitive benchmarking of key players by region

PESTLE Analysis

PORTER’s analysis

Value chain and supply chain analysis

Legal Aspects of Business by Region

Lucrative business opportunities with SWOT analysis

Recommendations

About Jadhavar Business Intelligence:

At Jadhavar Business Intelligence Pvt. Ltd., we believe growth is a collaborative journey. As a leading business consulting and market research company, empowering businesses with data-driven insights, strategic advisory, and investment facilitation. Founded in Pune and rooted in the 30-year legacy of the Jadhavar Group (established in 1995), we empower SMEs, MNCs, startups, NGOs, and educational institutions with data-driven strategies, mentorship, and investment networks to unlock their full potential.

Contact Jadhavar Business Intelligence Pvt. Ltd.:

Address: Office No. 1 & 2, Omkar Building,

Jadhav Nagar Lane No. 1, Vadgaon bk,

Pune - 411041

E-Mail: sales@jadhavarbusinessintelligence.com

Phone: +91 96048 41583,